Etizolam: Use and safety profile in children and adolescent
Introduction: Etizolam is a benzodiazepine that has anxiolytic, anticonvulsant, hypnotic, sedative, amnesic, and muscle-relaxant properties. It is used in adults with anxiety, depressive, somatization symptoms, generalized anxiety disorder, and panic disorder. Aims: The aim of the study was to chart...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Al Ameen Medical College,
2016-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: Etizolam is a benzodiazepine that has anxiolytic, anticonvulsant, hypnotic, sedative, amnesic, and muscle-relaxant properties. It is used in adults with anxiety, depressive, somatization symptoms, generalized anxiety disorder, and panic disorder. Aims: The aim of the study was to chart review the use and safety of Etizolam in children and adolescents. Settings and Design: This study was a retrospective chart review. Methods: Patients who are on Etizolam and had at least 2 weeks follow-up were included for the study. The indications, effectiveness, and adverse effects were noted. Statistical analysis used: Data was analysed using Epi Info 7. Descriptive statistics were used. Results: 57 (38.51%) patients had been treated with Etizolam. The mean age of children was 13.59 years (7-18 years). Amongst the patients prescribed Etizolam, 37 (64.91%) had a data of follow-up of at least 2 weeks. 25 (67.57%) patients had moderate to complete improvement, 5 (13.51%) had mild improvement and 7 (18.92%) had no improvement. The adverse events were noted only in 3 (8.11%) patients. Conclusions: Etizolam is effective in treating common psychiatric symptoms and disorders in children and adolescents and is well tolerated with minimal adverse effects. |
|---|---|
| Item Description: | 0974-1143 0974-1143 |